|
|
||||||||
Experimental Studies |
1 From the Center for Molecular Imaging Research, CNY149-5403, Department of Radiology, Massachusetts General Hospital, Bldg 149, 13th St, Charlestown, MA 02129. Received September 26, 2001; revision requested December 3; revision received December 17; accepted January 7, 2002. U.M. supported in part by a research grant from the RSNA Research and Education Foundation. Address correspondence to U.M. (e-mail: mahmood@helix.mgh.harvard.edu).
PURPOSE: To develop and test a multichannel reflectance imaging system for small animals on the basis of a previously developed single-channel setup.
MATERIALS AND METHODS: The imaging system was composed of modular parts, including a light source, excitation filters, emission filters, and a charged-coupled device for recording images. On the basis of generated excitation and absorption spectra of green fluorescent protein (GFP), tricarbocyanine 5.5 (Cy5.5), and indocyanine green (ICG), filters were selected to allow spectral separation and optimize resultant recorded signal. The system was tested by using a combination of the fluorochromes to confirm spectral separation. In vivo tests were performed in nude mice with tumors that expressed cathepsin B, which could be evaluated by using a Cy5.5-based activatable probe and GFP. For each in vivo tumor type and channel, statistical analysis was performed on the basis of signal intensity in the region of interest.
RESULTS: The different fluorochromes were readily distinguished with the system; characteristics such as power were determined for all wavelengths. The system demonstrated a linear response for GFP, a monotonic response for Cy5.5 over a range of more than three orders of magnitude of concentration, and a more complex response for ICG. In vivo analysis demonstrated the ability to image GFP expression and cathepsin B expression separately in tumors: As expected, marked differences were observed in GFP-expression imaging between tumor types (1,363 arbitrary units [AU] ± 236 [SD] vs 110 AU ± 11 for GFP-positive and GFP-negative tumors, respectively; P < .001), whereas similar cathepsin B expression (1,070 AU ± 285 vs 1,168 AU ± 367; P > .5) was observed. Histologic analysis confirmed in vivo findings.
CONCLUSION: Imaging multiple gene expressions simultaneously in vivo by using optical imaging is feasible.
© RSNA, 2002
Index terms: Experimental study Genes and genetics Neoplasms, experimental studies
This article has been cited by other articles:
![]() |
M. S. Gee, R. Upadhyay, H. Bergquist, H. Alencar, F. Reynolds, M. Maricevich, R. Weissleder, L. Josephson, and U. Mahmood Human Breast Cancer Tumor Models: Molecular Imaging of Drug Susceptibility and Dosing during HER2/neu-targeted Therapy Radiology, September 1, 2008; 248(3): 925 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Upadhyay, R. A. Sheth, R. Weissleder, and U. Mahmood Quantitative Real-time Catheter-based Fluorescence Molecular Imaging in Mice Radiology, November 1, 2007; 245(2): 523 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Alencar, M. A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder, and U. Mahmood Colonic Adenocarcinomas: Near-Infrared Microcatheter Imaging of Smart Probes for Early Detection--Study in Mice Radiology, July 1, 2007; 244(1): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, M. Iyer, A. Annala, L. Wu, M. Carey, and S. S. Gambhir Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice Physiol Genomics, January 12, 2006; 24(2): 173 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Funovics, R. Weissleder, and U. Mahmood Catheter-based in Vivo Imaging of Enzyme Activity and Gene Expression: Feasibility Study in Mice Radiology, June 1, 2004; 231(3): 659 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Botnar, A. S. Perez, S. Witte, A. J. Wiethoff, J. Laredo, J. Hamilton, W. Quist, E. C. Parsons Jr, A. Vaidya, A. Kolodziej, et al. In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent Circulation, April 27, 2004; 109(16): 2023 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Thrall Nanotechnology and Medicine Radiology, February 1, 2004; 230(2): 315 - 318. [Full Text] [PDF] |
||||
![]() |
M. F. Kircher, U. Mahmood, R. S. King, R. Weissleder, and L. Josephson A Multimodal Nanoparticle for Preoperative Magnetic Resonance Imaging and Intraoperative Optical Brain Tumor Delineation Cancer Res., December 1, 2003; 63(23): 8122 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Herschman Molecular Imaging: Looking at Problems, Seeing Solutions Science, October 24, 2003; 302(5645): 605 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Matrisian, G. W. Sledge Jr., and S. Mohla Extracellular Proteolysis and Cancer: Meeting Summary and Future Directions Cancer Res., October 1, 2003; 63(19): 6105 - 6109. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mahmood and R. Weissleder Near-Infrared Optical Imaging of Proteases in Cancer Mol. Cancer Ther., May 1, 2003; 2(5): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |